Literature DB >> 6201771

Heterogeneous immunocytochemical reactivities of oCRF-41-like material in the human hypothalamus, pituitary and gastrointestinal tract.

A C Nieuwenhuyzen Kruseman, E A Linton, J Ackland, G M Besser, P J Lowry.   

Abstract

Tissue specimens of human hypothalami, pituitaries and gastrointestinal tract were studied with an indirect immunoperoxidase technique using 6 different rabbit ovine corticotrophin-releasing factor (oCRF-41) antisera. All these antisera detected oCRF-41-like immunoreactivity in parvocellular neurones of the paraventricular nucleus of the hypothalamus and their nerve terminals adjacent to portal capillaries in the infundibular stem and posterior pituitary. 1 antiserum recognised oCRF-41-like immunoreactivity in the growth hormone cells of the anterior pituitary. 3 other antisera recognised oCRF-41-like immunoreactivity in mucosal cells of the gastric antrum. Pre-treatment of the antisera with sauvagine did not affect the immunostaining of the hypothalamic and gastric cells, but quenched the immunostaining of growth hormone cells in the anterior pituitary. It is concluded that (1) in human hypothalami a CRF is synthesized that is structurally very similar to oCRF-41; (2) in growth hormone cells of the anterior pituitary oCRF-41-like immunoreactive material can be detected which shares antigenic determinants with sauvagine; (3) in mucosal cells of the gastric antrum oCRF-41-like immunoreactivity is present that is comparable but probably not identical to hypothalamic CRF and is not sauvagine-like.

Entities:  

Mesh:

Substances:

Year:  1984        PMID: 6201771     DOI: 10.1159/000123893

Source DB:  PubMed          Journal:  Neuroendocrinology        ISSN: 0028-3835            Impact factor:   4.914


  4 in total

Review 1.  Effects of catecholamines on secretion of adrenocorticotrophic hormone (ACTH) in man.

Authors:  S Al-Damluji; L H Rees
Journal:  J Clin Pathol       Date:  1987-09       Impact factor: 3.411

Review 2.  Hypothesis: cytokines may be activated to cause depressive illness and chronic fatigue syndrome.

Authors:  E Ur; P D White; A Grossman
Journal:  Eur Arch Psychiatry Clin Neurosci       Date:  1992       Impact factor: 5.270

3.  Stimulation by hCRF of C-peptide release in type 2 diabetics during concomitant opioid receptor blockade.

Authors:  H Ehrenreich; C Kolmar; C Pittius; F D Goebel
Journal:  Klin Wochenschr       Date:  1988-02-15

Review 4.  The CRF Family of Neuropeptides and their Receptors - Mediators of the Central Stress Response.

Authors:  Nina Dedic; Alon Chen; Jan M Deussing
Journal:  Curr Mol Pharmacol       Date:  2018       Impact factor: 3.339

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.